维普中文期刊产品整合服务
32篇 您的检索式:作者名="Poxton IR"
    题名 作者 年代 出处 被引量
1A PCR approach to determine the distribution of toxin genes in closely related Clostridium species: Clostridium botulinum type C and D neurotoxins and C2 toxin, and Clostridi- um novyi alpha toxin 显示文摘Heffron A Poxton IR 2007J Med Microbiol2007,56,2:1
2Structure and function of lipopolysaccharides显示文摘Erridge C Bennett-Guerrero E Poxton IR 2002Microbes and Infection2002,4,8:1
3Antibodies to lipopolysaccharide显示文摘Poxton IR 1995Journal ofImmunological Methods1995,186,1:1
4The pathogenicity of Clostridium difficile显示文摘Poxton IR McCoubrey J Blair G 0,,8:1
5The pathogenicity of Clostridium difficile 显示文摘Poxton IR McCoubrey J Blair J 2001Clin Microbiol Infect2001,7,:1
6Endotoxin and nanobacteria in polycystic kidney disease 显示文摘Hjelle JT Miller-Hjelle MA Poxton IR 2000Kidney Int2000,57,6:1
7The distribution of, and antibody response to, the core lipopolysaccharide region of Escherichia coli isolated from the faeces of healthy humans and cattle显示文摘Gibbs ILl Stewart J Poxton IR 2004Journal of Medical Microbiology2004,53,10:1
8The pathogenicity of Clostridium difficile 显示文摘Poxton IR McCoubrey J Blair G 2001Clin Microbiol Infect2001,7,8:1
9Structure and function of lipopolysaccharides 显示文摘ERRIDGE C BENNETT-GUERRERO E POXTON IR 2002Microbes Infect2002,4,8:1
10Endotoxin and nanobacteria in polycystic kidney disease显示文摘Hjelle JT Miller-Hjelle MA Poxton IR 0,,:1
11Fidaxomicin:a new macrocyclic, RNA polymerase-inhibi- ting antibiotic for the treatment of Clostridium difficile infections 显示文摘Poxton IR 2010Future Microbiol2010,5,4:1
12Fidaxomicin: a new macrocyclic, RNA polymer- ase-inhibiting antibiotic for the treatment of Clostridium diffi- cile infections 显示文摘Poxton IR 2010Future Microbiol2010,5,4:1
13The pathogenicity of Clostridium difficile 显示文摘Poxton IR McCoubrey J Blair G 2001Clin Microbiol Infect2001,7,8:1
14Comparison of toxin and spore production in clinically relevant strains of Clostridium di~zcile 显示文摘Vohra P Poxton IR 2011Microbiolo- gy2011,157,5:1
15Mucosal and systemic antibody responses to the lipopolysaccharide of Escherichia coli O157 in health and disease显示文摘 Mccallum K Poxton IR 2001Med Microbiol2001,50,4:1
16Antibodies to lipopolysaccharide显示文摘Poxton IR 1995J Immunol Methods1995,186,1:1
17The pathogenicity of Clostridium difficile显示文摘 McCoubrey JM Blair G 2001Clin Microbiol Infect2001,7,:1
18Mucosa- associated bacterial flora of the human colon 显示文摘Poxton IR Brown R Sawyerr A 1997J Med Microbiol1997,46,1:1
19The pathogenicity of Clostridium difficile 显示文摘Poxton IR McCoubrey J Blair J 2001Clin Mierobiol Infect2001,7,:1
20Mucosal and systemic antibody responses to the lipopolysaccharide of Escherichia coli O157 in health and disease显示文摘CURRIE CG MCCALLUM K POXTON IR 2001Med Microbiol2001,50,4:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费